Another Day, Another Opioid Advisory Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
As opioid plan shifts into high gear, FDA sets June dates for proposed abuse-deterrent opioids from Teva and Pfizer that already have missed user fee goals.
You may also be interested in...
Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Biden COVID-19 Plan Would Grow Domestic Manufacturing Base
The proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
Biden Vaccination Plan Would Grow Domestic Manufacturing Base
Proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: